• Research Overview
• Cardiac Care and Education
• Epidemiology and Cancer Statistics
• Health Services and Policy
• Mental Health and Addiction
• Public Health and Society
• Trials and Statistics
  • About York Trials Unit
  • Trials and studies
  • Research methods
  • Meet the team
  • Collaborate with us
  • Patient and Public Involvement
  • SWATS
  • Privacy notice
  • NIHR RSS delivered by University of York and partners
• Nursing and midwifery research

Health economics

The health economics team at York Trials Unit evaluates the cost-effectiveness of interventions in a range of settings, in addition to conducting methodological research.

We provide economic evaluations alongside clinical trials. This involves within-trial analyses and longer-term model-based cost-effectiveness analyses. We are experienced in designing, undertaking, analysing and reporting economic evaluations, across a range of disease areas.

Examples of our health economic publications are listed below. Economic evaluations undertaken as part of a project are available on the relevant project webpage.

Corbacho Martín B, Brealey SD, Keding A, Richardson G, Torgerson DJ, Hewitt CE et al. Cost-effectiveness of surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: economic evaluation of UK FROST trial. Bone & Joint Open. 2021 May 24.

Ronaldson SJ, Keding A, Tharmanathan P et al. Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial [version 1; peer review: 2 approved]. F1000Research 2021, 10:821 (https://doi.org/10.12688/f1000research.55296.1)

Corbacho B, Keding A, Chuang LH et al. Comparison of the EQ-5D-5L and the EQ-5D-3L using individual patient data from the REFORM trial [version 1; peer review: awaiting peer review]. F1000Research 2021, 10:974 (https://doi.org/10.12688/f1000research.54554.1) 

Corbacho Martín B, Drummond M, Santos R, Jones E, Borras JM, Mestre-Ferrandiz J et al. Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries. The European Journal of Health Economics. 2020 Feb 5. https://doi.org/10.1007/s10198-020-01160-5

Bell, KJ, Corbacho Martin, MB, Ronaldson, SJ, Richardson, GA, Hood, K, Sanders, J, Robling, M & Torgerson, DJ 2019, 'Costs and Consequences of the Family Nurse Partnership (FNP) Programme in England: Evidence from the Building Blocks Trial', F1000research, vol. 8, no. 1640. https://doi.org/10.12688/f1000research.20149.1 

Stamuli E, Torgerson D, Northgraves M, Ronaldson S, Cherry L. Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment. Journal of Foot and Ankle Research. 2017 Dec 15;10. https://doi.org/10.1186/s13047-017-0240-3